Press ReleasesIndustrialsAspo Plc - Managers' Transactions - Patricia Allam By globenewswire June 17, 2025 0 0 Aspo Plc – Managers’ Transactions – Patricia Allam Aspo Plc Managers’ transactions June 17, 2025, at 5.30 p.m. Source: https://www.globenewswire.com/news-release/2025/06/17/3100860/0/en/Aspo-Plc-Managers-Transactions-Patricia-Allam.html Tags57636dateFI0009008072Helsinki:ASPOmanagersnewssourcetransactions Previous articleMediPharm Announces Voting Results from the 2025 Annual and Special Meeting of ShareholdersNext articleMTM Critical Metals signs MOU with Meteoric Resources After Successful Proof-of-Concept Beneficiation Test Work on Rare Earth Element-rich Mixed Rare Earth Carbonate Product at Meteoric’s Caldeira’s Project in Brazil globenewswire Commodities & Resources PTE Ltd. Announces Acquisition of Shares of Belmont Resources Inc. Pursuant to Private Placement July 3, 2025 APPLOVIN ALERT: Bragar Eagel & Squire, P.C. is Investigating AppLovin Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm July 3, 2025 Dizal’s ZEGFROVY® (sunvozertinib) Receives FDA Accelerated Approval as the Only Targeted Oral Treatment for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations July 3, 2025 First AML expands Tranche 2 leadership in Australia following major client wins across law and real estate July 3, 2025 ASIA’S 50 BEST BARS 2025 REVEALS THE ESTABLISHMENTS RANKED ON THE EXTENDED 51-100 LIST July 3, 2025 ASIA’S 50 BEST BARS 2025 REVEALS THE ESTABLISHMENTS RANKED ON THE EXTENDED 51-100 LIST July 3, 2025 Recent News ASIA’S 50 BEST BARS 2025 REVEALS THE ESTABLISHMENTS RANKED ON THE EXTENDED 51-100 LIST Dizal’s ZEGFROVY® (sunvozertinib) Receives FDA Accelerated Approval as the Only Targeted Oral Treatment for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations APPLOVIN ALERT: Bragar Eagel & Squire, P.C. is Investigating AppLovin Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm